Diagnostic impact of baseline cerebral blood flow in patients with acute ischemic stroke prior to intravenous recombinant tissue plasminogen activator therapy

Conclusion: These results suggest that rt-PA therapy for patients with severe cerebral perfusion defects may cause SICH and baseline CBF may contribute to identify patients at high risk for SICH after intravenous rt-PA therapy.

Source: Clinical Neurology and Neurosurgery - February 22, 2013 Category: Neurosurgery Authors: Masaki Ito, Tetsuyuki Yoshimoto, Masahito Kawabori, Shin Fujimoto, Tohru Yamauchi, Hideshi Yamaguchi, Kouichi Tokuda, Sadao Kaneko Tags: Original articles Source Type: research